Imbalances of CD4(+) T-cell subgroups in Crohn's disease and their relationship with disease activity and prognosis.

Chao K, Zhang S, Yao J, He Y, Chen B, Zeng Z, Zhong B, Zhong B, Chen M

J Gastroenterol Hepatol, 29(10):1808-1814, 01 Oct 2014

Cited by: 27 articles | PMID: 24720272

Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction.

Ye J, Wu Y, Li F, Wu T, Shao C, Lin Y, Wang W, Feng S, Zhong B, Zhong B

Therap Adv Gastroenterol, 12:1756284819879047, 26 Sep 2019

Cited by: 22 articles | PMID: 31632457 | PMCID: PMC6767749

Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients.

Shao C, Ye J, Li F, Lin Y, Wu T, Wang W, Feng S, Zhong B, Zhong B

Dig Dis Sci, 65(6):1850-1860, 13 Nov 2019

Cited by: 16 articles | PMID: 31724099

Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.

Shao C, Ye J, Li F, Feng S, Wang W, Zhong B, Zhong B

Dig Liver Dis, 51(10):1392-1399, 28 Mar 2019

Cited by: 15 articles | PMID: 30928418

Clinicopathological characteristics and prognostic factors of primary gastrointestinal lymphoma: a 22-year experience from South China.

Li M, Zhang S, Gu F, Xiao W, Yao J, Chao K, Chen M, Li J, Zhong B

Int J Clin Exp Pathol, 7(5):2718-2728, 15 Apr 2014

Cited by: 11 articles | PMID: 24966993 | PMCID: PMC4069930

Free full text in Europe PMC

Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study.

Ye J, Hu X, Wu T, Wu Y, Shao C, Li F, Lin Y, Feng S, Wang W, Zhong B, Zhong B

Diabetol Metab Syndr, 11:45, 15 Jun 2019

Cited by: 9 articles | PMID: 31223344 | PMCID: PMC6570947

Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma.

Wu Y, Zheng S, Yao J, Li M, Yang G, Zhang N, Zhang S, Zhong B

Oncotarget, 8(2):3018-3028, 01 Jan 2017

Cited by: 6 articles | PMID: 27935871 | PMCID: PMC5356860

Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.

Shi YW, He FP, Chen JJ, Deng H, Shi JP, Zhao CY, Mi YQ, Zou ZS, Zhou YJ, Di FS, Zheng RD, Du Q, Shang J, Yang RX, Popovic B, Zhong BH, Zhong BH, Fan JG

J Clin Transl Hepatol, 9(5):607-614, 23 Apr 2021

Cited by: 4 articles | PMID: 34722175 | PMCID: PMC8516831

Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment.

Shao C, Ye J, Li X, Lin Y, Feng S, Liao B, Wang W, Gong X, Zhong B, Zhong B

J Clin Transl Hepatol, 10(6):1013-1026, 24 Feb 2022

Cited by: 3 articles | PMID: 36381107 | PMCID: PMC9634785

Keratin 8 Mutations Were Associated With Susceptibility to Chronic Hepatitis B and Related Progression.

Ye J, Wu Y, Li M, Gong X, Zhong B, Zhong B

J Infect Dis, 221(3):464-473, 01 Jan 2020

Cited by: 3 articles | PMID: 31515557